文献速递产科母胎医学

不良妊娠结局与分娩后2-7年预测的30年母体心血管疾病风险

Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2-7 Years After Delivery.
PubMed 文献 · Obstet Gynecol · 2024-04-05

本研究为前瞻性Nulliparous妊娠结局-监测母亲心脏健康研究队列的二次分析,纳入4,273名初产妇,评估首次妊娠不良结局与分娩后2-7年Framingham风险评分预测的30年动脉粥样硬化性心血管疾病风险的关系。结果显示,妊娠期糖尿病、妊娠期高血压疾病和早产与更高的预测风险相关,且不良妊娠结局数量越多风险越高,而小于或大于胎龄儿与风险无一致关联。

要点

  • 首次妊娠发生妊娠期糖尿病、妊娠期高血压疾病或早产者,分娩后2-7年预测的30年动脉粥样硬化性心血管疾病风险更高。
  • 首次分娩时不良妊娠结局数量越多,预测的30年心血管疾病风险进行性升高。
  • 小于或大于胎龄儿与预测的30年动脉粥样硬化性心血管疾病风险无一致关联。

核心结论

  • 首次分娩时发生不良妊娠结局的个体,在分娩后2-7年预测的30年心血管疾病风险更高,且不良妊娠结局数量越多风险越高。

研究设计与样本

  • 本研究为前瞻性Nulliparous妊娠结局-监测母亲心脏健康研究纵向队列的二次分析,纳入4,273名个体,分娩后中位3.1年(四分位距2.5-3.7)评估。
  • 暴露为首次妊娠期间的不良妊娠结局(妊娠期糖尿病、妊娠期高血压疾病、早产、小于或大于胎龄儿出生体重),分别建模并次要分析不良妊娠结局累计数量(无、一个、两个及以上)。
  • 结局为分娩后2-7年通过Framingham风险评分预测的30年动脉粥样硬化性心血管疾病风险,分别以连续变量(每1%增量)和分类变量(预测风险≥10%为高预测风险)测量。
  • 采用线性回归和改良Poisson模型,并校正基线协变量。

主要发现

  • 在4,273名个体中,中位预测30年动脉粥样硬化性心血管疾病风险为2.2%(四分位距1.4-3.4),1.8%具有高预测风险。
  • 妊娠期糖尿病组最小二乘均值5.93 vs 无该结局组4.19,校正β=1.45(95%CI 1.14-1.75);妊娠期高血压疾病组4.95 vs 4.22,校正β=0.49(95%CI 0.31-0.68);早产组4.81 vs 4.27,校正β=0.47(95%CI 0.24-0.70)。
  • 妊娠期糖尿病组高预测风险8.7% vs 1.4%,校正RR 2.02(95%CI 1.14-3.59);妊娠期高血压疾病组4.4% vs 1.4%,校正RR 1.91(95%CI 1.17-3.13);早产组5.0% vs 1.5%,校正RR 2.26(95%CI 1.30-3.93)。
  • 与无不良妊娠结局组相比,一个不良妊娠结局组每1%动脉粥样硬化性心血管疾病风险为4.86 vs 4.09,校正β=0.59(95%CI 0.43-0.75);两个及以上组为5.51 vs 4.09,校正β=1.16(95%CI 0.82-1.50)。
  • 与无不良妊娠结局组相比,一个不良妊娠结局组高预测风险为3.8% vs 1.0%,校正RR 2.33(95%CI 1.40-3.88);两个及以上组为8.7% vs 1.0%,RR 3.43(95%CI 1.74-6.74)。

关键数值与推荐

  • 高预测风险定义为预测的30年动脉粥样硬化性心血管疾病风险≥10%。
  • 动脉粥样硬化性心血管疾病包括冠状动脉疾病或卒中。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether adverse pregnancy outcomes are associated with a higher predicted 30-year risk of atherosclerotic cardiovascular disease (CVD; ie, coronary artery disease or stroke). METHODS: This was a secondary analysis of the prospective Nulliparous Pregnancy Outcomes Study-Monitoring Mothers-to-Be Heart Health Study longitudinal cohort. The exposures were adverse pregnancy outcomes during the first pregnancy (ie, gestational diabetes mellitus [GDM], hypertensive disorder of pregnancy, preterm birth, and small- and large-for-gestational-age [SGA, LGA] birth weight) modeled individually and secondarily as the cumulative number of adverse pregnancy outcomes (ie, none, one, two or more). The outcome was the 30-year risk of atherosclerotic CVD predicted with the Framingham Risk Score assessed at 2-7 years after delivery. Risk was measured both continuously in increments of 1% and categorically, with high predicted risk defined as a predicted risk of atherosclerotic CVD of 10% or more. Linear regression and modified Poisson models were adjusted for baseline covariates. RESULTS: Among 4,273 individuals who were assessed at a median of 3.1 years after delivery (interquartile range 2.5-3.7), the median predicted 30-year atherosclerotic CVD risk was 2.2% (interquartile range 1.4-3.4), and 1.8% had high predicted risk. Individuals with GDM (least mean square 5.93 vs 4.19, adjusted β=1.45, 95% CI, 1.14-1.75), hypertensive disorder of pregnancy (4.95 vs 4.22, adjusted β=0.49, 95% CI, 0.31-0.68), and preterm birth (4.81 vs 4.27, adjusted β=0.47, 95% CI, 0.24-0.70) were more likely to have a higher absolute risk of atherosclerotic CVD. Similarly, individuals with GDM (8.7% vs 1.4%, adjusted risk ratio [RR] 2.02, 95% CI, 1.14-3.59), hypertensive disorder of pregnancy (4.4% vs 1.4%, adjusted RR 1.91, 95% CI, 1.17-3.13), and preterm birth (5.0% vs 1.5%, adjusted RR 2.26, 95% CI, 1.30-3.93) were more likely to have a high predicted risk of atherosclerotic CVD. A greater number of adverse pregnancy outcomes within the first birth was associated with progressively greater risks, including per 1% atherosclerotic CVD risk (one adverse pregnancy outcome: 4.86 vs 4.09, adjusted β=0.59, 95% CI, 0.43-0.75; two or more adverse pregnancy outcomes: 5.51 vs 4.09, adjusted β=1.16, 95% CI, 0.82-1.50), and a high predicted risk of atherosclerotic CVD (one adverse pregnancy outcome: 3.8% vs 1.0%, adjusted RR 2.33, 95% CI, 1.40-3.88; two or more adverse pregnancy outcomes: 8.7 vs 1.0%, RR 3.43, 95% CI, 1.74-6.74). Small and large for gestational age were not consistently associated with a higher atherosclerotic CVD risk. CONCLUSION: Individuals who experienced adverse pregnancy outcomes in their first birth were more likely to have a higher predicted 30-year risk of CVD measured at 2-7 years after delivery. The magnitude of risk was higher with a greater number of adverse pregnancy outcomes experienced.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Venkatesh KK, Khan SS, Yee LM, et al. Adverse Pregnancy Outcomes and Predicted 30-Year Risk of Maternal Cardiovascular Disease 2-7 Years After Delivery. Obstet Gynecol. 2024. PMID: 38574364. doi:10.1097/AOG.0000000000005569

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。